Cardiovascular Risk Marker Panel (CRMP1)

The Cardiovascular Risk Marker Panel (CRMP1) is a comprehensive diagnostic tool designed to evaluate multiple independent pathways to heart disease. Unlike a standard lipid panel, which primarily focuses on the concentration of fats in the blood, the CRMP1 looks deeper at the metabolic and inflammatory processes that drive the development of atherosclerosis (plaque buildup). This panel is essential for identifying "hidden" risks that may be missed by conventional screenings.

Key components of the CRMP1 include:

Apolipoprotein B (ApoB): Often considered a more accurate predictor of cardiovascular risk than LDL cholesterol alone, ApoB measures the total number of potentially atherogenic (plaque-forming) particles in your blood.

Lipoprotein(a) [Lp(a)]: A genetically determined marker that promotes blood clotting and plaque formation. High levels are a significant independent risk factor that is rarely screened in routine checkups.

High-Sensitivity C-Reactive Protein (hs-CRP): A critical marker of systemic inflammation. Chronic low-grade inflammation in the arterial walls is a primary driver of heart disease and stroke.

Comprehensive Lipids: Including total cholesterol, HDL, and Triglycerides to provide the necessary baseline for traditional risk calculations.

By facilitating the CRMP1, AvoVita Wellness provides you with a robust risk profile. This data-heavy approach allows you and your healthcare provider to differentiate between high cholesterol that may be benign and high-risk inflammatory states that require immediate intervention.

Standard cholesterol tests measure the weight of cholesterol within your particles, but the Labcorp NMR LipoProfile® measures the actual number and size of the particles themselves. Using sophisticated Nuclear Magnetic Resonance (NMR) technology, this test identifies individuals who may have "normal" cholesterol numbers but a high number of small, dense LDL particles—the type most likely to penetrate the arterial wall and cause damage.

Why NMR Technology is the Modern Gold Standard:

LDL Particle Number (LDL-P): Clinical research indicates that the number of particles is a significantly better predictor of heart disease than the concentration of cholesterol (LDL-C).

LDL Size & Pattern: Identifies whether your LDL is composed of large, buoyant "Pattern A" particles or small, dense "Pattern B" particles, which are significantly more atherogenic.

Insulin Resistance (LP-IR) Score: A unique marker derived from the lipoprotein particles that provides early insight into your risk for Type 2 diabetes and metabolic syndrome, both of which are major drivers of heart disease.

This facilitated analysis is particularly valuable for those with metabolic syndrome or those currently on statin therapy who need to know if their treatment is effectively reducing their particle count, not just their cholesterol weight.

Please note, the sample report below is an illustration of what is reported, the format of the actual report is much more text based and not as visually appealing. 

The D-Dimer test is a specialized diagnostic marker used to measure the presence of protein fragments that are produced when the body breaks down a blood clot. While often used in acute settings to rule out deep vein thrombosis (DVT) or pulmonary embolism, it also serves as a valuable long-term indicator of "hypercoagulability"—a state where the blood is more prone to forming dangerous clots.

In the context of cardiovascular health, an elevated D-Dimer may signal ongoing vascular stress or an underlying inflammatory condition that increases the risk of arterial events. AvoVita Wellness facilitates private access to D-Dimer testing for those who require precise monitoring of their coagulation status. Because this test has a high negative predictive value, a normal result provides powerful reassurance that significant active clotting is not currently occurring, making it a staple for comprehensive vascular monitoring.

To ensure a complete understanding of your vascular health, AvoVita Wellness facilitates a suite of foundational supporting tests. These markers are essential for identifying secondary metabolic and inflammatory drivers that directly impact long-term heart and arterial integrity. By grouping these specific assays with our advanced panels, we provide the high-fidelity data needed to manage cardiovascular risk from every angle.

Our supporting cardiovascular menu includes:

Apolipoprotein A1 and B: This specialized assessment provides a clear ratio of your protective (A1) versus potentially atherogenic (B) particles, offering a more precise risk calculation than standard cholesterol measurements alone.

Lipoprotein(a): We facilitate the testing of this genetically determined marker, which is a major independent risk factor for premature heart disease and is rarely included in routine provincial screenings.

Homocysteine, Total: Elevated levels of this amino acid are linked to increased arterial damage and blood clot risk; monitoring this marker is a vital step in maintaining vascular elasticity.

C-Reactive Protein (Standard & High Sensitivity): We facilitate both standard CRP and High-Sensitivity CRP (hs-CRP) to distinguish between general systemic inflammation and the specific low-grade inflammation within the arterial walls.

Essential Fatty Acid Profile: This analysis measures the balance of Omega-3 and Omega-6 fatty acids in your system, providing data-driven insights into your body’s internal inflammatory regulation and heart-protective nutrient status.

Myeloperoxidase (MPO) Antibodies, IgG: A specialized marker used to assess localized inflammation and oxidative stress specifically within the vascular lining.

Standard Lipid Panel: We include the foundational metrics of Total Cholesterol, HDL, LDL, and Triglycerides to provide the necessary baseline for all traditional cardiovascular risk assessments.